Vascepa Gets Coveted Event-Prevention Label
]]>(MedPage Today) -- WASHINGTON--Icosapent ethyl, the prescription fish-oil product sold as Vascepa, may now be marketed for reducing risk of cardiovascular events in adults with triglyceride levels of 150 mg/dL or higher, the FDA said late Friday...
Read more »